Cerebroprotein hydrolysate preparation and designing method thereof

A brain protein hydrolyzate and preparation technology, applied in the field of pharmaceutical preparations, can solve problems such as insufficient test accuracy, inability to sensitively investigate interactions, and inability to accurately find the best point, etc., to achieve the effect of prescription science

Active Publication Date: 2017-11-07
BEIHUA UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are still many deficiencies in the current prescription screening of gastric floating preparations, for example, it needs to rely on the experience of researchers, or even if orthogonal tests can be used to screen prescriptions, the test accuracy is not enough, and the selected test values ​​are only Close to the optimal value, it is impossible to find the optimal point accurately, and the conditions are optimized based on experience, and the interaction between various factors cannot be sensitively examined, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cerebroprotein hydrolysate preparation and designing method thereof
  • Cerebroprotein hydrolysate preparation and designing method thereof
  • Cerebroprotein hydrolysate preparation and designing method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0067] A cerebroprotein hydrolyzate preparation is designed by the following method:

[0068] 1. Choice of dosage form.

[0069] The cerebroprotein hydrolyzate was treated in artificial gastric juice and artificial intestinal juice for MTT experiment, and the dosage form was selected according to the repair rate of cerebroprotein hydrolyzate in the stomach and intestine to the oxidative damage model, as follows.

[0070] (1) Determination of the dosage of cerebroprotein hydrolyzate:

[0071] the PC 12 Cells were seeded in 96-well plates for research, and each experimental group was set up according to the following table. The specific sample addition and experimental methods were as follows:

[0072] The cell concentration was 1ml containing 1.0×10 5 The cell suspension of two cells was inoculated in the 96-well plate of the normal cell control group, the damaged cell control group, and the test product 1-3 group with different concentrations, and 100 μl was added to each w...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a cerebroprotein hydrolysate preparation and a designing method thereof, belonging to the technical field of a pharmaceutical preparation. The method comprises the following steps: selection of dosage form: according to the repair rate of cerebroprotein hydrolysate to oxidative damage models in the stomach and intestines, selecting the dosage form; design of prescriptions: according to a star point design-response surface method, designing different prescriptions by taking preset pharmaceutical adjuncts as an influencing factor and an accumulative releasing rate as a response variable; experiments: preparing the cerebroprotein hydrolysate preparation according to the prescriptions, and respectively conducting releasing experiments; modeling: performing model fitting of the experiment results according to the star point design-response surface method, so as to obtain a fitted equation by taking the influencing factor as an independent variable and the accumulative releasing rate as a response variable; optimization of the prescriptions: according to the fitted equation, optimizing and screening the independent variable, so as to obtain the independent variable corresponding to the highest accumulative releasing rate, namely the optimal prescription. The method can be used for optimizing the pharmaceutical prescription, and has the scientific, stable and feasible advantages.

Description

technical field [0001] The invention relates to the technical field of pharmaceutical preparations, in particular to a cerebroprotein hydrolyzate preparation and a design method thereof. Background technique [0002] Brain protein hydrolyzate is extracted and separated from animal brain tissue. It is easy to cross the biofilm and pass through the blood-brain barrier. It promotes cell metabolism and increases brain activity in various ways. At the same time, it acts on the nerve center and nourishes nerve cells. Meta-repair provides amino acids and promotes synapse formation, thereby protecting nerve cells and improving nervous system dysfunction. [0003] In recent years, the domestic drug is mainly administered by injection, with less oral administration and low bioavailability. Therefore, how to deliver and preserve such drugs is the goal that pharmacy should persist in exploring. [0004] Gastric floating preparations are a type of preparations prepared based on the pri...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/01A61K9/22A61K47/10A61K47/38A61K47/32A61K47/26A61P25/00G06F19/12
CPCA61K9/0002A61K9/0065A61K9/2013A61K9/2018A61K9/2027A61K9/2054A61K38/012G16B5/00
Inventor 王曼力杜培革安丽萍赵南晰盛瑜苑广信李洪宇韩笑徐广宇孙晶波郭笑杨昕祺郭冰洁
Owner BEIHUA UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products